Thyroid volumes and serum VEGF levels in dyslipidemic patients: effects of statin treatment

Kadriye Aydın Neşe Ersöz Gülçelik Murat Tuncel Cafer Balci Şafak Akın Nese Cinar Firuzan Fırat Ozer Meltem Çağlar Aydan Usman Alper Gürlek

Published in: Turkish journal of medical sciences (2019)

Although statin treatment decreases serum VEGF levels in dyslipidemic patients without thyroid nodules, it has no lowering effect on serum VEGF levels in patients with thyroid nodules. The decrease in thyroid nodule volume with statin treatment was associated with neither metabolic parameters nor serum VEGF levels.

Keyphrases

end stage renal disease
vascular endothelial growth factor
endothelial cells
newly diagnosed
chronic kidney disease
cardiovascular disease
ejection fraction
coronary artery disease
prognostic factors
peritoneal dialysis
type diabetes